Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
BEIJING ZHENDONG GUANGMING PHARMACEUTICAL RESEARCH INSTITUTE CO., LTD. has 1 pending office action in Chemistry & Materials. This involves a distinct examiner and a single art unit. The focus on chemistry suggests that the company's current intellectual property efforts are directed toward pharmaceutical or material science developments.
XU, XIAOYUN is the busiest examiner for this portfolio. This examiner is managing 1 busiest examiner pending office action, which is the only pending action currently active for the company. Having the entire workload under a single examiner allows for a centralized prosecution process, where the applicant can focus on the specific requirements of one individual.
Practitioners should consider that the prosecution outcome is heavily dependent on the examiner's perspective on the chemical arts. The alignment of the technology area with the assigned art unit indicates that the application is being reviewed by specialists in chemistry. Effective prosecution will require a detailed technical response that addresses the specific prior art and legal standards applied within this art unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| XU, XIAOYUN | 1 | 60.0% | +31.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18255302 | METHOD FOR DETECTING MONOSACCHARIDE AND OLIGOSACCHARIDE CONTENT AND FINGERPRINT SPECTURM OF COMPOUND SOPHORA FLAVESCENS INJECTION | XU, XIAOYUN | — |
| Art Unit | Apps |
|---|---|
| 1797 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18255302 | METHOD FOR DETECTING MONOSACCHARIDE AND OLIGOSACCHARIDE CONTENT AND FINGERPRINT SPECTURM OF COMPOUND SOPHORA FLAVESCENS INJECTION | XU, XIAOYUN | 1797 | §103 | Non-Final OA | — | Pending | May 31, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial